Updated Jul 16, 2026
Farrow Jeffrey S has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.32M.
Jeffrey S. Farrow is associated with Tarsus Pharmaceuticals, Inc., as indicated by recent SEC filings. Specific details about his role and contributions to the company are not widely documented in public sources.
| Role | See Remarks |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 14.4K | $60.95 | $877K |
| 2026-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 27.9K | — | |
| 2026-03-19 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 2.2K | $67.00 | $146K |
| 2026-03-19 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 2.1K | $68.71 | $147K |
| 2026-03-19 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 2.1K | $69.42 | $147K |
| 2026-03-17 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 13.0K | — |
Jeffrey S. Farrow is associated with Tarsus Pharmaceuticals, Inc., as indicated by recent SEC filings. Specific details about his role and contributions to the company are not widely documented in public sources.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.32M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Farrow Jeffrey S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.